No Data
Johnson & Johnson Raised to Outperform From Market Perform by Leerink Partners
Leerink Partners Upgrades Johnson & Johnson to Outperform, Announces $265 Price Target
An Unloved Health-care Stock Gets a Welcome Nod in This AI-obsessed Market
Global Colorectal Cancer Diagnostics and Therapeutics Market Anticipates Impressive Growth Trajectory at a CAGR of ~9% by 2034 | DelveInsight
GHX Announces 2025 GHXcellence Award Winners
Prevent Blindness to Host the 2026 ASPECT Patient Engagement Summit and Eyes on Capitol Hill Legislative Advocacy Day in Washington, D.C.
MostTalentlessTrader : literally all low revenue with high PE stocks![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
terribletrader : Jesus oracle at 258?? i thought my cost basis at 210 was high
Rippled : dca wins. u can hold long it will eventually pay off. Don't dismay
107527535 : will drop summore?
Tempus AI : As for PLTL, my friend bought a lot of shares and has been holding them for a while. She won't sell even if the price drops. They entered Intel at 17 yuan per share and still haven't sold to this day.
View more comments...